PTAB challenges

Proceedings overview

There is one active AIA trial proceeding on file for US patent 10998017, an Inter Partes Review (IPR). The proceeding is currently pending, meaning no claims have been invalidated or sustained by a final written decision, leaving all claims untested by the PTAB at this stage. This gives a defendant facing assertion of this patent an opportunity to monitor or potentially participate in the ongoing IPR challenge.

IPR2026-00241 — [Apple Inc.](/litigations/by-plaintiff/Apple%20Inc.) v. Wecrevention Inc.

• Type: Inter Partes Review
• Filed: 2026-02-13
• Status: Pending (The proceeding is ongoing, and no final decision has been issued yet).
• Judge panel: Information regarding the specific judge panel for IPR2026-00241 is not yet publicly available in the provided data or general search results at this stage of the proceeding.
• Petition grounds: Details of the specific claims challenged, prior art asserted, and statutory bases (§ 102 / § 103 / § 112) of the petition are not yet publicly available in the provided data.
• Institution decision: As of 2026-05-29, an institution decision has not been issued for IPR2026-00241, as the case is still pending. The statutory deadline for an institution decision is typically six months from the petition's filing date.
• Final Written Decision: Not applicable, as the proceeding is still pending.
• Settlement / termination: Not applicable, as the proceeding is still pending.
• Appeal: Not applicable, as no Final Written Decision has been issued.
• Defensive value: This proceeding indicates that Apple Inc. is actively challenging the patent. While the outcome is unknown, a pending IPR creates uncertainty regarding the validity of the patent's claims. For a defendant, this means the patent is under scrutiny, and if the IPR is instituted, it could lead to claim cancellation, potentially weakening the patent owner's assertion position.

Strategic summary

Currently, all claims of US10998017 remain UNTESTED by a Final Written Decision from the PTAB. The patent is subject to one active Inter Partes Review (IPR2026-00241) initiated by Apple Inc. As the IPR is in its early stages, no claims have been canceled or sustained by the PTAB.

The estoppel landscape is presently clear for other potential challengers, as no Final Written Decision has been issued in IPR2026-00241. Consequently, the § 315(e)(2) estoppel provisions do not yet apply to the petitioner (Apple Inc.) or their privies, nor to any other party. This means that, at this time, all prior-art grounds remain theoretically available for assertion in other challenges or litigation, subject to other procedural rules.

A clear pattern signal is the involvement of Apple Inc. as the petitioner, indicating a significant entity is challenging the patent. The current assignee, Wecrevention Inc., is also involved in ongoing litigation in the Eastern and Western Districts of Texas related to this patent, as noted by Unified Patents. This suggests an active assertion campaign for US10998017, which often leads to IPR filings as a defensive measure by accused infringers.

Recommended next steps

Given that IPR2026-00241 is pending, the most critical upcoming milestone is the Institution Decision. The PTAB has a statutory one-year trial deadline from institution, but the institution decision itself typically occurs within six months of the petition filing. Therefore, an institution decision for IPR2026-00241 can be anticipated around August 2026.

Defendants facing assertion of US10998017 should closely monitor the progress of IPR2026-00241, particularly the institution decision. If the IPR is instituted, the grounds on which it is instituted will be crucial for understanding the potential for claim invalidation. If the IPR proceeds to a Final Written Decision, the outcome will significantly impact the strength of the patent.